Our data shows that the JAK2/STAT5 signal transduction pathway is constitutively activated in megakaryocytic leukemic patients that prompted us to analyze the patients with AML, ALL and CML. This evidence concerns the gene JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive.